SHANGHAI, Aug. 12, 2024 /PRNewswire/ -- On August 13th 2024, Ocumension Therapeutics ("OcuMension") announced an agreement with Alcon Inc. ("Alcon", and collectively with OcuMension, the "Parties") ...
Alcon ALC recently announced the closing of its deal to acquire BELKIN Vision. Per the terms of the agreement, Alcon will have access to BELKIN Vision’s Direct Selective Laser Trabeculoplasty (“DSLT”) ...
Alcon demonstrates potential resilience vs. market shocks, with favorable balance sheet risk and positive EPS forecasts for FY26. Read why ALC stock is a Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results